March 5, 2018 / 7:23 AM / in 5 months

BRIEF-Astrazeneca Says EMA Accepts Submission For Forxiga In Adults With Type-1 Diabetes​

March 5 (Reuters) - Astrazeneca Plc:

* ‍EUROPEAN MEDICINES AGENCY ACCEPTS REGULATORY SUBMISSION FOR FORXIGA IN ADULTS WITH TYPE-1 DIABETES​

* ‍SUBMISSION ACCEPTANCE IS BASED ON PHASE III DATA FROM DEPICT CLINICAL PROGRAMME FOR FORXIGA IN T1D​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below